Dr. Benjamin Inbeh Chung, MD

Dr. Chung practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Chung's NPI, 1205945920, was assigned on August 29, 2006. Dr. Chung graduated from Sidney Kimmel Medical College in 1999. Dr. Chung's California license number on file is A95419.

Dr. Chung's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Chung's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Chung is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Chung to 1 more hospital, named with a free account. Dr. Chung's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chung practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chung's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chung is board certified in urology by the American Board of Urology. Dmand AI has Dr. Chung's licenses on file in 4 states: California, Iowa, Ohio and Pennsylvania.

Dmand AI lists bladder removal, kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer, prostate surgery, transurethral procedures and urinary endoscopy among the conditions Dr. Chung treats.

CMS data shows 502 Medicare services from Dr. Chung across 10 procedure codes in 2024, for 386 Medicare patients. Medicare paid $70,970 for them.

CMS counts 386 Medicare patients who saw Dr. Chung in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chung's median patient age at 66, with 25% women.

In 2024, Dr. Chung wrote 52 Medicare Part D claims for 29 patients. 96% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $230 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chung for performance year 2024, reported as part of a group. Dr. Chung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chung as offering telehealth. CMS counts 11 procedures of prostate resection by Dr. Chung, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 216 papers to Dr. Chung, published from 2009 to 2025. 2022 was the busiest year, with 28. The most frequent topics are Kidney Neoplasms, Nephrectomy and Prostatic Neoplasms. Dr. Chung has published most often in J Endourol. Dr. Chung's most frequent co-authors are Steven Lee Chang, MD, MS, John Thomas Leppert, MD and James D. Brooks, MD.

Dmand AI links Dr. Chung to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Kidney Neoplasms. Stanford University sponsors the most, 2.

CMS Open Payments shows 132 general payments to Dr. Chung from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 74% of the total. Ethicon Inc. paid the most, $61,352.

Dmand AI lists 1 award for Dr. Chung, most recently CMS Stage 1 EHR in 2013.

Dr. Chung graduated from Sidney Kimmel Medical College in 1999.

Dr. Chung is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.